| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Non-Customized |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Antiviral Favipiravir Powder CAS 259793-96-9 Favipiravir
Favipiravir, as a new broad-spectrum anti-RNA virus drug, was approved for marketing in Japan in March 2014 for antiviral treatment of influenza A and B.
){kind=link}